Evidence map›Paper›PMID 26078920›Full record

ArticleBritish biotechnology journal2014

Martha Nakaye, Freddie Bwanga, Herbert Itabangi, Iramiot J Stanley, Mwambi Bashir, Joel Bazira

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British biotechnology journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Beta-lactamase resistance genes inAfrican journal of laboratory medicine · 2022
    Review
  7. Phenotypic and Genotypic Characteristics of UropathogenicMicrobial drug resistance (Larchmont, N.Y.) · 2022
    Article
  8. Prevalence of ESBL and AmpC genes inNew microbes and new infections · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martha NakayeDepartment of Microbiology, Mbarara University of Science and Technology, P.O Box 1410, Mbarara, Uganda.
Freddie BwangaDepartment of Microbiology, Makerere College of Health sciences, P.O 7072 Kampala, Uganda.
Herbert ItabangiDepartment of Microbiology, Mbarara University of Science and Technology, P.O Box 1410, Mbarara, Uganda.
Iramiot J StanleyDepartment of Microbiology, Mbarara University of Science and Technology, P.O Box 1410, Mbarara, Uganda.
Mwambi BashirDepartment of Microbiology, Mbarara University of Science and Technology, P.O Box 1410, Mbarara, Uganda.
Joel BaziraDepartment of Microbiology, Mbarara University of Science and Technology, P.O Box 1410, Mbarara, Uganda.

Funding

Medical Education for Services to All Ugandans (MESAU)R24TW008886 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI SEWANKAMBO, NELSON K · 2010 to 2015
$9.2M
FIC NIH HHS R24 TW008886
6 · The paper itself

Abstract

aimTo characterize STUDY

designLaboratory-based descriptive cross-sectional study. PLACE AND DURATION OF STUDY: Microbiology Department, Mbarara Regional Referral Hospital and MBN clinical Laboratories, between May to September 2013. METHODOLOGY: This study included 293

resultsPlasmid mediated

conclusionOur findings showed that prevalence of

Indexed as

AmpC beta lactamaseantibioticEnterobacteriaceaeresistant

Identifiers

PMID26078920
PMCPMC4465074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.